Cargando…

Exclusion of constitutional p53 mutations as a cause of genetic susceptibility to colorectal cancer.

Detalles Bibliográficos
Autores principales:	Bhagirath, T., Condie, A., Dunlop, M. G., Wyllie, A. H., Prosser, J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1993
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968627/ https://www.ncbi.nlm.nih.gov/pubmed/8398698

Ejemplares similares

Constitutional p53 mutation in a non-Li-Fraumeni cancer family.
por: Prosser, J., et al.
Publicado: (1992)

APC mutation analysis by chemical cleavage of mismatch and a protein truncation assay in familial adenomatous polyposis.
por: Prosser, J., et al.
Publicado: (1994)

Mutations in p53 do not account for heritable breast cancer: a study in five affected families.
por: Prosser, J., et al.
Publicado: (1991)

Mutation of the p53 gene precedes aneuploid clonal divergence in colorectal carcinoma.
por: Carder, P. J., et al.
Publicado: (1995)

Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage
por: Zerdoumi, Yasmine, et al.
Publicado: (2017)

Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage
por: Zerdoumi, Yasmine, et al.
Publicado: (2017)

p53 Mutations and DNA Ploidy in Colorectal Adenocarcinomas
por: Campomenosi, Paola, et al.
Publicado: (1998)

Deletion analysis of chromosome 8p in sporadic colorectal adenomas.
por: Cunningham, C., et al.
Publicado: (1994)

Ribosomal Protein Mutations Result in Constitutive p53 Protein Degradation through Impairment of the AKT Pathway
por: Antunes, Ana T., et al.
Publicado: (2015)

Exclusive Association of p53 Mutation with Super-High Methylation of Tumor Suppressor Genes in the p53 Pathway in a Unique Gastric Cancer Phenotype
por: Waraya, Mina, et al.
Publicado: (2015)

Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas.
por: Dix, B., et al.
Publicado: (1994)

Overexpression of p53 mRNA in colorectal cancer and its relationship to p53 gene mutation.
por: el-Mahdani, N., et al.
Publicado: (1997)

Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas.
por: Smith, D. R., et al.
Publicado: (1996)

Butyrate supplementation regulates expression of chromosome segregation 1-like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer
por: Chang, Chun-Chao, et al.
Publicado: (2022)

A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignancies.
por: Speiser, P., et al.
Publicado: (1996)

Colorectal carcinoma in Hong Kong: epidemiology and genetic mutations.
por: Yuen, S. T., et al.
Publicado: (1997)

Constitutional mutations of cancer susceptibility genes in the health workers professionally exposed to cytostatic drugs
por: Janiszewska, H, et al.
Publicado: (2011)

Functional Polymorphisms in the p53 Pathway Genes on the Genetic Susceptibility to Zika Virus Teratogenesis
por: Gomes, Julia A., et al.
Publicado: (2021)

Genetic Nature of the Constitutional States of Cancer Susceptibility and Resistance in Mice and Men
por: Strong, Leonell C.
Publicado: (1944)

Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma
por: Wong, N A C S, et al.
Publicado: (2001)

P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers.
por: Lasky, T, et al.
Publicado: (1996)

Constitutional Mutations in RTEL1 Cause Severe Dyskeratosis Congenita
por: Walne, Amanda J., et al.
Publicado: (2013)

p53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs.
por: Malcomson, R. D., et al.
Publicado: (1995)

Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment
por: Hrstka, Roman, et al.
Publicado: (2009)

Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene
por: Rahman, N, et al.
Publicado: (2000)

p53 mutation and expression in lymphoma.
por: Adamson, D. J., et al.
Publicado: (1995)

KRAS and TP53 Mutations in Colorectal Carcinoma
por: Al-Kuraya, Khawla S.
Publicado: (2009)

Wiskott-Aldrich syndrome gene mutations modulate cancer susceptibility in the p53(±) murine model
por: Keszei, Marton, et al.
Publicado: (2018)

Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer
por: Li, Zheqi, et al.
Publicado: (2022)

Aspirin-induced nuclear translocation of NFκB and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiency
por: Din, F V N, et al.
Publicado: (2005)

cDNA sequencing improves the detection of P53 missense mutations in colorectal cancer
por: Szybka, Malgorzata, et al.
Publicado: (2009)

Functional repair of p53 mutation in colorectal cancer cells using trans-splicing
por: He, Xingxing, et al.
Publicado: (2014)

KRAS, p53 and BRAF Gene Mutations and Aneuploidy in Sporadic Colorectal Cancer Progression
por: Calistri, Daniele, et al.
Publicado: (2006)

Effect of KRAS mutations and p53 expression on the postoperative prognosis of patients with colorectal cancer
por: Wang, Lingfeng, et al.
Publicado: (2022)

P53 mutations in gastric carcinomas.
por: Seruca, R., et al.
Publicado: (1992)

Protein adduction causes non-mutational inhibition of p53 tumor suppressor
por: Gokulan, Ravindran Caspa, et al.
Publicado: (2023)

p53 Dysregulation in Breast Cancer: Insights on Mutations in the TP53 Network and p53 Isoform Expression
por: Steffens Reinhardt, Luiza, et al.
Publicado: (2023)

Constitutional Causes of Caries
por: Black, H. H.
Publicado: (1862)

Genetic Alterations in Thyroid Tumor Progression: Association with p53 Gene Mutations
por: Ito, Takashi, et al.
Publicado: (1993)

Mutations in p53, p53 protein overexpression and breast cancer survival
por: Rossner, Pavel, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_bctqbqfvflv1tptkg82e1ia35b